Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. Additionally we are shipping LRG1 Antibodies (73) and LRG1 Kits (32) and many more products for this protein.
Showing 10 out of 24 products:
Human LRG1 Protein expressed in Human Cells - ABIN2005678
ODonnell, Druhan, Avalos: Molecular characterization and expression analysis of leucine-rich alpha2-glycoprotein, a novel marker of granulocytic differentiation. in Journal of leukocyte biology 2002
Human LRG1 Protein expressed in Wheat germ - ABIN1309718
Boström, Wu, Jedrychowski, Korde, Ye, Lo, Rasbach, Boström, Choi, Long, Kajimura, Zingaretti, Vind, Tu, Cinti, Højlund, Gygi, Spiegelman: A PGC1-?-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. in Nature 2012
Data show that leucine-rich-alpha-2-glycoprotein 1 (LRG1) is markedly up-regulated and serves as an independent factor of poor outcomes in hepatocellular carcinoma (HCC (show FAM126A Proteins)).
Reanalysis of a total of 47 MDS (show PAFAH1B1 Proteins) patients revealed biomarker candidates, with alpha-2-HS-glycoprotein (show AHSG Proteins) and leucine-rich alpha-2-glycoprotein as the most promising candidates.
Two of these proteins were verified in a separate patient cohort: values of CRP (show CRP Proteins) and LRG1 combined gave a highly significant indication of extended survival post one week of radiotherapy treatment.
Findings suggest that LRG1 promotes invasion and migration of glioma cells through TGF-beta (show TGFB1 Proteins) signaling pathway.
Data found LRG1 as a promising candidate marker for detection of epithelial ovarian cancer (EOC) and the combination of LRG1 and CA125 (show MUC16 Proteins) showed improved performance to distinguish EOC including early stage EOC from non-cases compared to CA125 (show MUC16 Proteins).
LGR1 (show FSHR Proteins) is involved in the inhibition of HCC (show FAM126A Proteins) metastasis.
silencing the expression of LRG1 suppresses the growth of glioblastoma U251 cells in vitro and in vivo, suggesting that LRG1 may play a critical role in glioblastoma development, and it may have potential clinical implications in glioblastoma therapy.
Higher LRG1 is a significant predictor for arterial stiffness, endothelial function, and peripheral arterial disease.
The blood proteins IGF1 (show IGF1 Proteins), IGF2, IBP2, IBP3 (show IGFBP3 Proteins) and A2GL have been proposed as indirect biomarkers for detection of GH administration and as putative biomarkers for breast cancer diagnosis.
LRG1 potentially offered clinical value in directing personal treatment for endometrial carcinoma patients
Loss of LRG is associated with Lewis lung carcinoma.
Human LRG (hLRG) concentration in the cerebrospinal fluid (CSF (show CSF2 Proteins)) was measured and hLRG expression in post-mortem human cerebral cortex and mouse LRG (mLRG) in the brain were examined.
Mice lacking Lrg1 develop a mild retinal vascular phenotype but exhibit a significant reduction in pathological ocular angiogenesis.
cDNA clones for murine leucine-rich alpha2-glycoprotein were isolated. Expression of LRG during differentiation of 32Dcl3G cells preceded the expression of lactoferrin (show LTF Proteins) and gelatinase but followed myeloperoxidase (show MPO Proteins).
The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002
, leucine-rich alpha-2-glycoprotein 1
, leucine-rich alpha-2-glycoprotein-like
, leucine rich alpha 2 glycoprotein